Oct 20, 2023 / Payment Basics

Skilled nursing facility services payment system

Research Areas:

Post-Acute Care

Oct 18, 2023 / Congressional Testimony

Testimony: Ensuring Medicare beneficiaries’ access to care and reducing burden for providers (Energy and Commerce)

Research Areas:

Physicians And Other Health Professionals

Sep 29, 2023 / Comment Letters

MedPAC’s response to a Congressional Request for Information on Improving Access to Health Care in Rural and Underserved Areas

Research Areas:

Beneficiaries and Coverage, Regional Issues

Sep 19, 2023 / Congressional Testimony

Statement for the Record: Examining Policies to Improve Seniors’ Access to Innovative Drugs, Medical Devices, and Technology (Energy and Commerce)

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests

Sep 11, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on CY 2024 revisions to payment policies under the physician fee schedule and other changes to Part B payment policies

Research Areas:

Medicare Spending and Financing, Physicians And Other Health Professionals

Sep 11, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on the payment systems for hospital outpatient departments and ambulatory surgical centers for 2024

Research Areas:

Hospitals, Medicare Spending and Financing

Sep 01, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on the remedy for the 340B-acquired drug payment policy for calendar years 2018-2022

Research Areas:

Drugs, Devices, and Tests, Medicare Spending and Financing

Aug 25, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on the home health prospective payment system for CY 2024

Research Areas:

Medicare Spending and Financing, Post-Acute Care

Aug 25, 2023 / Comment Letters

MedPAC comment on CMS’s proposed rule on the end-stage renal disease payment system for CY 2024

Research Areas:

Ambulatory Care Settings, Medicare Spending and Financing

Aug 25, 2023 / Comment Letters

MedPAC comment on CMS’s notice on transitional coverage for emerging technologies

Research Areas:

Beneficiaries and Coverage, Drugs, Devices, and Tests